Stay updated on Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study record content and navigation, which indicates the study page is currently inaccessible.
    Difference
    17%
    Check dated 2026-09-20T00:49:52.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page’s Revision tag was updated from v3.6.5 to v3.6.6, signaling a new version of the page content or its underlying template.
    Difference
    0.1%
    Check dated 2026-08-29T20:58:22.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page now presents an error page indicating the content is unavailable, including the HTML skeleton and header/footer, which removes the study information and linked documents from view.
    Difference
    16%
    Check dated 2026-08-08T17:46:50.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor system update; no study details or visible content were altered.
    Difference
    0.1%
    Check dated 2026-07-25T10:51:35.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a new site build. This change appears to be a minor platform update and does not reflect changes to the study content on this page.
    Difference
    0.1%
    Check dated 2026-07-03T21:53:33.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    The site software revision was updated from v3.6.0 to v3.6.2, indicating a minor release. No changes to the study details or visible page content are introduced.
    Difference
    0.1%
    Check dated 2026-06-26T19:49:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.